Need Help? Chat Now With a Live Representative!

ARG Celebrates 15-Year Anniversary

ARG Celebrates 15-Year Anniversary

ARG Celebrates 15-Year Anniversary

October 22, 2019

ARG's 15-yr. anniversary celebration starts today! In 2004, from Staunton, VA, our two founders offered project management and clinical monitoring. Now with offices in Charlottesville, London, Amsterdam, and Warsaw, ARG offers a full suite of global clinical trial management services, leading technology solutions, along with our signature customer service. Thank you to all of our partners along the way, and a special thanks to all of the members of the ARG team who have been driven by the belief that "everyone deserves to be well."

Please visit our silos dedicated to our areas of therapeutic expertise:

About ARG:

ARG is an oncology, immunology, rare and neurodegenerative disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. Founded in 2004 with the vision that every project should be highly individualized and visible, ARG has experienced consistent growth across the globe, expanding our reach to include drug and device strategic consulting, clinical trial management services, and clinical data and analytic solutions. ARG is a disrupter, using first-in-class technology platforms along with relationship-driven flexibility to optimize clinical studies because we believe everyone deserves to be well.

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Breaking Ground in Medicine: Our Role in the Approval of Bivigam by ADMA Biologics

Since 2004, ARG has been working in the immunology space, using our individualized approach to optimize the likelihood of successful […]

March 8, 2024
ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

ARG and Humacyte Collaborate on Human Acellular Vessel (HAV) Program Advancements in Vascular Trauma

CHARLOTTESVILLE, VIRGINIA – ARG (Atlantic Research Group) proudly announces its ongoing collaboration with Humacyte, a leading biotechnology company, on the […]

February 23, 2024
Revolutionizing Treatment: Our Contribution to Humacyte’s Latest Innovation

Revolutionizing Treatment: Our Contribution to Humacyte’s Latest Innovation

In 2014, ARG began working with Humacyte on their Human Acellular Vessel (HAV) interposition graft program, which included three separate […]

February 7, 2024
GO TO TOP